Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies.

Virus research - 1 Mar 2000

DeMaula C D, Bonneau K R, MacLachlan N J

Abstract excerpt

Six neutralizing monoclonal antibodies (Mabs) and nine neutralization resistant viral variants (escape-mutant viruses (EMVs)) were used to further characterize the neutralization determinants of bluetongue virus serotype 10 (BTV10). The EMVs were produced by sequential passage of a highly cell culture adapted United States prototype strain of BTV10 in the presence of individual neutralizing Mabs. Mabs were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Antibodies, Monoclonal
Share to Capsid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Capsid Proteins

Share to Cricetinae

Share to Neutralization Tests

Share to RNA, Viral

Share to Serotyping

Source

Identifiers

PMID: 10773319
DOI: 10.1016/s0168-1702(00)00130-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies.PMID 10773319Read ↗

Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroupSemantic proximity Read ↗

Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17.Semantic proximity Read ↗

Impact of VP2 structure on antigenicity: comparison of BTV1 and the highly virulent BTV8 serotypeSemantic proximity Read ↗

Bluetongue virus serotype 17 sequence variation associated with neutralization.Semantic proximity Read ↗

Identification of an amino acid on VP2 that affects neutralization of bluetongue virus serotype 10.Semantic proximity Read ↗

Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes.Semantic proximity Read ↗

Genetic characteristics and pathogenicity of the first bluetongue virus serotype 20 strain isolated in ChinaSemantic proximity Read ↗

A complex neutralization domain of bluetongue virus serotype 17 defines a virulence-associated marker.Semantic proximity Read ↗

Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo.Semantic proximity Read ↗

A Synthetic Biology Approach for a Vaccine Platform against Known and Newly Emerging Serotypes of Bluetongue VirusSemantic proximity Read ↗

Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus SerotypesSemantic proximity Read ↗

The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.